Payment overview · 2025
General Payments
$213.87
3 reported records · 2 companies
Healthcare provider profile · identity verified
Joshua Ranum, MD
Allopathic & Osteopathic Physicians|Internal Medicine · HETTINGER, ND · NPI 1609035120
Verified facts
What the public records show
CMS Open Payments records show Joshua Ranum, MD received $213.87 in general payments during 2025 across 3 reported records.
Amgen Inc. accounted for 81.8% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Mounjaro.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 173 claims for Jardiance by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported MOUNJARO as an associated drug or biological on 186719 records involving 66436 distinct recipient NPIs. Public Medicare Part D data also shows 64 claims for Mounjaro by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRULICITY as an associated drug or biological on 71 records involving 57 distinct recipient NPIs. Public Medicare Part D data also shows 53 claims for Trulicity by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Amgen Inc. | Unresolved — no canonical attribution shown | $175.00 | 81.8% | 1 | 2025 |
| Lilly USA, LLC | Unresolved — no canonical attribution shown | $38.87 | 18.2% | 2 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Consulting Fee | $175.00 | 1 |
| Food and Beverage | $38.87 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| PROLIA Normalized: prolia |
Biological | Amgen Inc. | $175.00 | 1 | 2025 |
Source payment records
|
|||||
| ZEPBOUND Normalized: zepbound |
Drug | Lilly USA, LLC | $19.72 | 1 | 2025 |
Source payment records
|
|||||
| MOUNJARO Normalized: mounjaro |
Drug | Lilly USA, LLC | $19.15 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| MOUNJARO mounjaro |
2025 | Mounjaro | 2024 | 64 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
173 | 29 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | MOUNJARO open payments reported associated product |
CMS Open Payments — General Payments 186719 supporting records · 66436 recipient NPIs · example record 1186464455 |
Mounjaro · 2024 Exact normalized brand match · 1 Part D row |
64 | 13 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | TRULICITY open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 57 recipient NPIs · example record 1186464601 |
Trulicity · 2024 Exact normalized brand match · 1 Part D row |
53 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 595 | 115 |
| Atorvastatin Calcium | Atorvastatin Calcium | 536 | 114 |
| Lisinopril | Lisinopril | 472 | 91 |
| Metoprolol Succinate | Metoprolol Succinate | 467 | 97 |
| Losartan Potassium | Losartan Potassium | 460 | 96 |
| Tamsulosin Hcl | Tamsulosin Hcl | 438 | 92 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 419 | 108 |
| Pantoprazole Sodium | Pantoprazole Sodium | 395 | 87 |
| Amlodipine Besylate | Amlodipine Besylate | 374 | 89 |
| Metformin Hcl | Metformin Hcl | 349 | 79 |
| Omeprazole | Omeprazole | 332 | 51 |
| Furosemide | Furosemide | 300 | 69 |
| Allopurinol | Allopurinol | 296 | 54 |
| Eliquis | Apixaban | 283 | 54 |
| Simvastatin | Simvastatin | 268 | 58 |
| Potassium Chloride | Potassium Chloride | 237 | 41 |
| Gabapentin | Gabapentin | 231 | 55 |
| Tramadol Hcl | Tramadol Hcl | 228 | 27 |
| Carvedilol | Carvedilol | 217 | 48 |
| Sertraline Hcl | Sertraline Hcl | 179 | 25 |
| Metformin Hcl Er | Metformin Hcl | 174 | 35 |
| Jardiance | Empagliflozin | 173 | 29 |
| Celecoxib | Celecoxib | 167 | 31 |
| Spironolactone | Spironolactone | 167 | 44 |
| Duloxetine Hcl | Duloxetine Hcl | 163 | 26 |
| Prednisone | Prednisone | 157 | 38 |
| Buspirone Hcl | Buspirone Hcl | 152 | 20 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 142 | 35 |
| Finasteride | Finasteride | 141 | 31 |
| Trazodone Hcl | Trazodone Hcl | 126 | 24 |
| Glimepiride | Glimepiride | 115 | 27 |
| Oxycodone Hcl | Oxycodone Hcl | 115 | 20 |
| Atenolol | Atenolol | 114 | 25 |
| Clopidogrel | Clopidogrel Bisulfate | 112 | 32 |
| Metoprolol Tartrate | Metoprolol Tartrate | 109 | 22 |
| Baclofen | Baclofen | 102 | suppressed |
| Bupropion Xl | Bupropion Hcl | 94 | 15 |
| Bumetanide | Bumetanide | 90 | 12 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 90 | 16 |
| Hydrochlorothiazide | Hydrochlorothiazide | 86 | 27 |
| Alendronate Sodium | Alendronate Sodium | 84 | 18 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 83 | 23 |
| Fluoxetine Hcl | Fluoxetine Hcl | 83 | 13 |
| Mirtazapine | Mirtazapine | 81 | 18 |
| Montelukast Sodium | Montelukast Sodium | 80 | 17 |
| Torsemide | Torsemide | 80 | 16 |
| Warfarin Sodium | Warfarin Sodium | 80 | 11 |
| Zolpidem Tartrate | Zolpidem Tartrate | 80 | 17 |
| Fluticasone Propionate | Fluticasone Propionate | 77 | 16 |
| Pravastatin Sodium | Pravastatin Sodium | 77 | 11 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 77 | 13 |
| Xarelto | Rivaroxaban | 77 | 13 |
| Dutasteride | Dutasteride | 72 | 21 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 67 | 20 |
| Clonazepam | Clonazepam | 66 | suppressed |
| Lamotrigine | Lamotrigine | 65 | suppressed |
| Meloxicam | Meloxicam | 64 | suppressed |
| Mounjaro | Tirzepatide | 64 | 13 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 63 | 14 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 61 | 21 |
| Ozempic | Semaglutide | 60 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 59 | 13 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 59 | suppressed |
| Novolog Flexpen | Insulin Aspart | 55 | 16 |
| Quetiapine Fumarate | Quetiapine Fumarate | 55 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 55 | 28 |
| Valsartan | Valsartan | 55 | 15 |
| Famotidine | Famotidine | 54 | 17 |
| Soliqua 100-33 | Insulin Glargine/Lixisenatide | 53 | 11 |
| Trulicity | Dulaglutide | 53 | suppressed |
| Ezetimibe | Ezetimibe | 52 | 15 |
| Irbesartan | Irbesartan | 52 | 13 |
| Lorazepam | Lorazepam | 52 | 14 |
| Alprazolam | Alprazolam | 51 | 11 |
| Ventolin Hfa | Albuterol Sulfate | 51 | 14 |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 50 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 48 | 12 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 47 | 14 |
| Citalopram Hbr | Citalopram Hydrobromide | 46 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 46 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 45 | 12 |
| Ondansetron Odt | Ondansetron | 45 | 13 |
| Jantoven | Warfarin Sodium | 44 | 13 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 44 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 43 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 42 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 41 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 40 | 11 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 39 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 39 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 39 | 16 |
| Metoclopramide Hcl | Metoclopramide Hcl | 39 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 39 | suppressed |
| Synthroid | Levothyroxine Sodium | 36 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 35 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 35 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 34 | suppressed |
| Aripiprazole | Aripiprazole | 33 | suppressed |
| Pregabalin | Pregabalin | 33 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 33 | suppressed |
| Methotrexate | Methotrexate Sodium | 32 | suppressed |
| Nitroglycerin | Nitroglycerin | 32 | 14 |
| Sotalol | Sotalol Hcl | 31 | suppressed |
| Carbamazepine | Carbamazepine | 29 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 29 | suppressed |
| Estradiol | Estradiol | 29 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 29 | suppressed |
| Hydromorphone Hcl | Hydromorphone Hcl | 29 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 28 | suppressed |
| Roflumilast | Roflumilast | 28 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 27 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 27 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 27 | suppressed |
| Memantine Hcl | Memantine Hcl | 27 | suppressed |
| Diltiazem 24hr Er (Xr) | Diltiazem Hcl | 26 | suppressed |
| Levetiracetam | Levetiracetam | 26 | suppressed |
| Rexulti | Brexpiprazole | 26 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 25 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 24 | suppressed |
| Primidone | Primidone | 24 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 24 | suppressed |
| Eszopiclone | Eszopiclone | 23 | suppressed |
| Methocarbamol | Methocarbamol | 22 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 21 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 20 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 20 | suppressed |
| Dulera | Mometasone/Formoterol | 20 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 20 | suppressed |
| Olanzapine | Olanzapine | 20 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 19 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 19 | suppressed |
| Repatha Syringe | Evolocumab | 19 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 18 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 18 | suppressed |
| Fentanyl | Fentanyl | 18 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 18 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 18 | suppressed |
| Myrbetriq | Mirabegron | 18 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 18 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 18 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 17 | suppressed |
| Glipizide Er | Glipizide | 17 | suppressed |
| Klor-Con M10 | Potassium Chloride | 17 | suppressed |
| Lacosamide | Lacosamide | 17 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 17 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 17 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 17 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 16 | suppressed |
| Ramipril | Ramipril | 16 | suppressed |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 16 | 13 |
| Cholestyramine Light | Cholestyramine | 15 | suppressed |
| Diazepam | Diazepam | 15 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 15 | suppressed |
| Temazepam | Temazepam | 15 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 15 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 15 | suppressed |
| Avonex (4 Pack) | Interferon Beta-1a | 14 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 14 | 13 |
| Diclofenac Sodium-Misoprostol | Diclofenac Sodium/Misoprostol | 14 | suppressed |
| Lansoprazole | Lansoprazole | 14 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 14 | suppressed |
| Sucralfate | Sucralfate | 14 | suppressed |
| Trospium Chloride Er | Trospium Chloride | 14 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 13 | 13 |
| Breo Ellipta | Fluticasone/Vilanterol | 13 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 13 | suppressed |
| Budesonide Dr | Budesonide | 13 | suppressed |
| Genvoya | Elviteg/Cob/Emtri/Tenof Alafen | 13 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 13 | suppressed |
| Methadone Hcl | Methadone Hcl | 13 | suppressed |
| Novolog | Insulin Aspart | 13 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 13 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 13 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 13 | 11 |
| Febuxostat | Febuxostat | 12 | suppressed |
| Lyrica | Pregabalin | 12 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 12 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 12 | suppressed |
| Tradjenta | Linagliptin | 12 | suppressed |
| Unifine Pentips | Pen Needle, Diabetic | 12 | suppressed |
| Zafirlukast | Zafirlukast | 12 | suppressed |
| Calcitriol | Calcitriol | 11 | suppressed |
| Dexamethasone | Dexamethasone | 11 | suppressed |
| Eplerenone | Eplerenone | 11 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 11 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 11 | suppressed |
| Hydrocortisone | Hydrocortisone | 11 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 11 | suppressed |
| Latanoprost | Latanoprost | 11 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 11 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 11 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 11 | suppressed |
| Topiramate | Topiramate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $213.87 · 3 records | Amgen Inc. | MOUNJARO, PROLIA, ZEPBOUND | 3 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Mounjaro play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Lilly USA, LLC?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error